Cancer Therapy-Related Cardiac Dysfunction in Patients Treated with a Combination of an Immune Checkpoint Inhibitor and Doxorubicin

SIMPLE SUMMARY: Immune checkpoint inhibitors (ICIs) have demonstrated promising efficacy against various types of cancer. Although ICIs exhibit strong anti-cancer effects, they can cause adverse cardiac events. However, only a few case reports have focused on whether ICIs and cardiotoxic agents incr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seon-Hwa, Cho, Iksung, You, Seng-Chan, Cha, Min-Jae, Chang, Jee-Suk, Kim, William D., Go, Kyu-yong, Kim, Dae-Young, Seo, Jiwon, Shim, Chi-Young, Hong, Geu-Ru, Kang, Seok-Min, Ha, Jong-Won, Rha, Sun-Young, Kim, Hyo-Song
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100163/
https://www.ncbi.nlm.nih.gov/pubmed/35565449
http://dx.doi.org/10.3390/cancers14092320

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100163/
https://www.ncbi.nlm.nih.gov/pubmed/35565449
http://dx.doi.org/10.3390/cancers14092320

Ejemplares similares